Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali Ҷилди 3 № 3 (2022)

PHENOTYPIC PREDICTORS AND BIOMARKERS FOR FORECASTING THE EFFECTIVENESS OF ANTIMICROBIAL THERAPY

Мухсинов Фарход Мунисович, Ливерко Ирина Владимировна

Дар манбаъ хондан PDF

Аннотатсия

In order to assess the forecast of the effectiveness of antimicrobial therapy, phenotypic predictors characterizing the seriousness of the inflammatory process and the level of beta-lactamase activity (BLA) of blood serum were studied in 55 patients with exacerbation of chronic obstructive pulmonary disease and 40 patients with hospital-acquired pneumonia. According to the results, it was found that the serum beta-lactamase activity level is determined by phenotypic and clinical variables: age over 60 years, severe respiratory pathology, fever over 380, peripheral blood leukocyte level over 10x109, C-reactive protein over 40 mg/L and saturation less than 93%, correlating with an increase in UAV levels, and are predictors of low efficacy of treatment with beta-lactam antibiotics. A direct correlation was revealed between the level of serum beta-lactamase activity and the duration of antimicrobial therapy during the year (r=+0.86, p=0.001), the number of antimicrobial drugs prescribed simultaneously (r=+0.69, p=0.001), the fact of receiving beta-lactam reserve antibiotics – cefepime, imipenem, meropenem (r=+0.71, p=0.001), the fact of prescribing reserve antibiotics not related to the beta-lactam series – rifampicin, azithromycin, vancomycin, linezolid, levofloxacin (r=+0.59, p=0.001). Predicting the effectiveness of successful treatment with antibacterial drugs of the first-line beta-lactam group in the framework of evidence-based medicine, the need to determine the level of beta-lactamase activity of biological substrates is justified. Assessment of the level of beta-lactamase activity before the start of antibiotic therapy will reduce the unjustified use of beta-lactam antibiotics by up to 30%.

бета-лактамазная активность, эффективность антимикробной терапии, бета-лактамные антибиотики, предикторы неэффективности, прогноз антибактериальной терапииbeta-lactamase activity, effectiveness of antimicrobial therapy, beta-lactam antibiotics, predictors of inefficiency, prognosis of antibacterial therapybeta-laktamaz faolligi, antimikrob terapiyaning samaradorligi, beta-laktam antibiotiklari, samarasizlik belgilari, antibakterial terapiya prognozi.

Манбаи метамаълумот: бойгонии OAI-PMH-и маҷалла · Sindex матни пурраро нигоҳ намедорад, ба манбаъ пайванд медиҳад.

Иқтибос гирифтан

APA 7
Мухсинов Фарход Мунисович & Ливерко Ирина Владимировна (2022). PHENOTYPIC PREDICTORS AND BIOMARKERS FOR FORECASTING THE EFFECTIVENESS OF ANTIMICROBIAL THERAPY. Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali, 3(3).
GOST R 7.0.5
Мухсинов Фарход Мунисович, Ливерко Ирина Владимировна PHENOTYPIC PREDICTORS AND BIOMARKERS FOR FORECASTING THE EFFECTIVENESS OF ANTIMICROBIAL THERAPY // Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali. 2022. Т. 3. № 3.
BibTeX
@article{мунисович2022,
  author  = {Мухсинов Фарход Мунисович and Ливерко Ирина Владимировна},
  title   = {PHENOTYPIC PREDICTORS AND BIOMARKERS FOR FORECASTING THE EFFECTIVENESS OF ANTIMICROBIAL THERAPY},
  journal = {Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali},
  year    = {2022},
  volume  = {3},
  number  = {3}
}
RIS
TY  - JOUR
AU  - Мухсинов Фарход Мунисович
AU  - Ливерко Ирина Владимировна
TI  - PHENOTYPIC PREDICTORS AND BIOMARKERS FOR FORECASTING THE EFFECTIVENESS OF ANTIMICROBIAL THERAPY
JO  - Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali
PY  - 2022
VL  - 3
IS  - 3
ER  -